Walleye Capital’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Buy |
362,610
+256,644
| +242% | +$8.34M | 0.05% | 219 |
|
|
2025
Q1 | $4M | Sell |
105,966
-42,390
| -29% | -$1.6M | 0.02% | 414 |
|
|
2024
Q4 | $12.1M | Buy |
148,356
+90,140
| +155% | +$7.38M | 0.03% | 220 |
|
|
2024
Q3 | $6.65M | Buy |
+58,216
| New | +$6.65M | 0.01% | 359 |
|
|
2024
Q2 | – | Sell |
-29,707
| Closed | -$2.03M | – | 2892 |
|
|
2024
Q1 | $2.03M | Sell |
29,707
-84,214
| -74% | -$5.75M | ﹤0.01% | 769 |
|
|
2023
Q4 | $7.15M | Buy |
+113,921
| New | +$7.15M | 0.02% | 266 |
|
|
2023
Q3 | – | Sell |
-59,041
| Closed | -$2.95M | – | 2792 |
|
|
2023
Q2 | $2.95M | Sell |
59,041
-28,842
| -33% | -$1.44M | 0.01% | 404 |
|
|
2023
Q1 | $3.29M | Sell |
87,883
-55,333
| -39% | -$2.07M | 0.05% | 382 |
|
|
2022
Q4 | $6.87M | Buy |
143,216
+83,956
| +142% | +$4.03M | 0.13% | 197 |
|
|
2022
Q3 | $1.42M | Sell |
59,260
-103,865
| -64% | -$2.49M | 0.03% | 578 |
|
|
2022
Q2 | $3.55M | Buy |
163,125
+93,673
| +135% | +$2.04M | 0.1% | 225 |
|
|
2022
Q1 | $1.68M | Buy |
+69,452
| New | +$1.68M | 0.04% | 402 |
|